Bristol-Myers Squibb Co.

BMYNYSE • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
54.19 USD
↗ 0.19 (0.35%)🟢PRE MARKET (AS OF 07:24 AM EDT)
🟢Market: OPEN

Bristol-Myers Squibb Co. (BMY) trades at $54.19 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include exceptional Return on Equity (36.3%) and a bullish Golden Cross on the moving averages. On the valuation side, BMY appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 18, 2026.

Open?$54.07
High?$54.19
Low?$54.03
Prev. Close?$54.00
Volume?61.8K
Avg. Volume?11.6M
VWAP?$54.15
Rel. Volume?0.01x
Bid / Ask
Bid?$53.90 × 200
Ask?$54.23 × 1.4K
Spread?$0.33
Midpoint?$54.07
Valuation & Ratios
Market Cap?110.3B
Shares Out?2.0B
Float?2.0B
Float %?99.9%
P/E Ratio?15.16
P/B Ratio?5.49
EPS?$3.56
Dividend?4.60%
Ex-Dividend?2026-07-02
News
Profile
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Immunology & Autoimmune
Employees
32.5K
Market Cap
110.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.bms.com
Listed
1952-06-23
Address
ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NJ 08543
Phone: (609) 252-4621
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
48
Momentum?
35
Short Sent.?
57
Piotroski F-Score?6/9Mixed
Altman Z-Score?2.35Grey
Confidence?73%Moderate
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?1.89%Low
Short Interest?38.5M
Days to Cover?3.5
Free Float2.0B
Avg Daily Volume11.1M
Settlement Date2026-05-29
Financial Health
Current Ratio?1.42Adequate
Quick Ratio?1.28Adequate
Cash Ratio?0.50Adequate
Debt/Equity?2.22High
ValuationATTRACTIVELY VALUEDvs 10 peers + S&P 500
Score
94/100
P/E?
Peers
100
S&P
80
15.2CHEAP▾
P/B?
Peers
80
S&P
34
5.49FAIR▾
P/S?
Peers
100
S&P
61
2.27CHEAP▾
P/FCF?
Peers
100
S&P
90
9.3CHEAP▾
EV/EBITDA?
Peers
90
S&P
76
10.7CHEAP▾
EV/Sales?
Peers
100
S&P
61
2.99CHEAP▾
Returns & Efficiency
ROE?
Peers
56
S&P
84
36.3%STRONG▾
ROA?
Peers
40
S&P
68
8.4%STRONG▾
Cash Flow & Enterprise
FCF?$11.9B
Enterprise Value?$145.2B
Fundamentals ratios updated end of day
MarketsMoversWatchlist